Global Companion Diagnostic Tests Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Companion Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Companion Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Companion Diagnostic Tests market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Companion Diagnostic Tests market has been segmented into:
Protein Detection
DNA Detection
Hybridization
Biomarker
Others
By Application, Companion Diagnostic Tests has been segmented into:
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Diagnostic Tests market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Diagnostic Tests markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Diagnostic Tests market.
The report offers in-depth assessment of the growth and other aspects of the Companion Diagnostic Tests market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Companion Diagnostic Tests Market Share Analysis
Companion Diagnostic Tests competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Diagnostic Tests sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Diagnostic Tests sales, revenue and market share for each player covered in this report.
The major players covered in Companion Diagnostic Tests are:
F. Hoffman LA Roche Ltd.
Siemens Healthcare GmBH
Agilent Technologies, Inc.
QIAGEN, Illumina, Inc.
AGENDIA NV
Abbott
BioMerieux SA, BioGenex
Genomic Health, Inc.
Thermo Fisher Scientific, Inc.
Table of Contents
1 Companion Diagnostic Tests Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Tests
1.2 Classification of Companion Diagnostic Tests by Type
1.2.1 Global Companion Diagnostic Tests Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Diagnostic Tests Revenue Market Share by Type in 2019
1.2.3 Protein Detection
1.2.4 DNA Detection
1.2.5 Hybridization
1.2.6 Biomarker
1.2.7 Others
1.3 Global Companion Diagnostic Tests Market by Application
1.3.1 Overview: Global Companion Diagnostic Tests Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Global Companion Diagnostic Tests Market by Regions
1.4.1 Global Companion Diagnostic Tests Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Diagnostic Tests (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffman LA Roche Ltd.
2.1.1 F. Hoffman LA Roche Ltd. Details
2.1.2 F. Hoffman LA Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffman LA Roche Ltd. SWOT Analysis
2.1.4 F. Hoffman LA Roche Ltd. Product and Services
2.1.5 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.2 Siemens Healthcare GmBH
2.2.1 Siemens Healthcare GmBH Details
2.2.2 Siemens Healthcare GmBH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Siemens Healthcare GmBH SWOT Analysis
2.2.4 Siemens Healthcare GmBH Product and Services
2.2.5 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.3 Agilent Technologies, Inc.
2.3.1 Agilent Technologies, Inc. Details
2.3.2 Agilent Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Agilent Technologies, Inc. SWOT Analysis
2.3.4 Agilent Technologies, Inc. Product and Services
2.3.5 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.4 QIAGEN, Illumina, Inc.
2.4.1 QIAGEN, Illumina, Inc. Details
2.4.2 QIAGEN, Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 QIAGEN, Illumina, Inc. SWOT Analysis
2.4.4 QIAGEN, Illumina, Inc. Product and Services
2.4.5 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.5 AGENDIA NV
2.5.1 AGENDIA NV Details
2.5.2 AGENDIA NV Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AGENDIA NV SWOT Analysis
2.5.4 AGENDIA NV Product and Services
2.5.5 AGENDIA NV Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioMerieux SA, BioGenex
2.7.1 BioMerieux SA, BioGenex Details
2.7.2 BioMerieux SA, BioGenex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioMerieux SA, BioGenex SWOT Analysis
2.7.4 BioMerieux SA, BioGenex Product and Services
2.7.5 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genomic Health, Inc.
2.8.1 Genomic Health, Inc. Details
2.8.2 Genomic Health, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genomic Health, Inc. SWOT Analysis
2.8.4 Genomic Health, Inc. Product and Services
2.8.5 Genomic Health, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific, Inc.
2.9.1 Thermo Fisher Scientific, Inc. Details
2.9.2 Thermo Fisher Scientific, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific, Inc. SWOT Analysis
2.9.4 Thermo Fisher Scientific, Inc. Product and Services
2.9.5 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Diagnostic Tests Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Tests Players Market Share
3.2.2 Top 10 Companion Diagnostic Tests Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Diagnostic Tests Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.5 South America Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
5 North America Companion Diagnostic Tests Revenue by Countries
5.1 North America Companion Diagnostic Tests Revenue by Countries (2015-2020)
5.2 USA Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6 Europe Companion Diagnostic Tests Revenue by Countries
6.1 Europe Companion Diagnostic Tests Revenue by Countries (2015-2020)
6.2 Germany Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.3 UK Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.4 France Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Diagnostic Tests Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Tests Revenue by Countries (2015-2020)
7.2 China Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.5 India Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
8 South America Companion Diagnostic Tests Revenue by Countries
8.1 South America Companion Diagnostic Tests Revenue by Countries (2015-2020)
8.2 Brazil Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Diagnostic Tests by Countries
9.1 Middle East & Africa Companion Diagnostic Tests Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Diagnostic Tests Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Diagnostic Tests Market Forecast by Type (2019-2024)
10.3 Protein Detection Revenue Growth Rate (2015-2025)
10.4 DNA Detection Revenue Growth Rate (2015-2025)
10.5 Hybridization Revenue Growth Rate (2015-2025)
10.6 Biomarker Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Companion Diagnostic Tests Market Segment by Application
11.1 Global Companion Diagnostic Tests Revenue Market Share by Application (2015-2020)
11.2 Companion Diagnostic Tests Market Forecast by Application (2019-2024)
11.3 Pharmaceutical and Biotechnology Companies Revenue Growth (2015-2020)
11.4 Medical Device Companies Revenue Growth (2015-2020)
11.5 Research Institutes Revenue Growth (2015-2020)
12 Global Companion Diagnostic Tests Market Size Forecast (2021-2025)
12.1 Global Companion Diagnostic Tests Market Size Forecast (2021-2025)
12.2 Global Companion Diagnostic Tests Market Forecast by Regions (2021-2025)
12.3 North America Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.4 Europe Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.6 South America Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Companion Diagnostic Tests Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Companion Diagnostic Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Companion Diagnostic Tests Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Companion Diagnostic Tests Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. F. Hoffman LA Roche Ltd. Corporate Information, Location and Competitors
Table 6. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Major Business
Table 7. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 8. F. Hoffman LA Roche Ltd. SWOT Analysis
Table 9. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product and Solutions
Table 10. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Siemens Healthcare GmBH Corporate Information, Location and Competitors
Table 12. Siemens Healthcare GmBH Companion Diagnostic Tests Major Business
Table 13. Siemens Healthcare GmBH Companion Diagnostic Tests Total Revenue (USD Million) (2018-2019)
Table 14. Siemens Healthcare GmBH SWOT Analysis
Table 15. Siemens Healthcare GmBH Companion Diagnostic Tests Product and Solutions
Table 16. Siemens Healthcare GmBH Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Agilent Technologies, Inc. Corporate Information, Location and Competitors
Table 18. Agilent Technologies, Inc. Companion Diagnostic Tests Major Business
Table 19. Agilent Technologies, Inc. Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 20. Agilent Technologies, Inc. SWOT Analysis
Table 21. Agilent Technologies, Inc. Companion Diagnostic Tests Product and Solutions
Table 22. Agilent Technologies, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. QIAGEN, Illumina, Inc. Corporate Information, Location and Competitors
Table 24. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Major Business
Table 25. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 26. QIAGEN, Illumina, Inc. SWOT Analysis
Table 27. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product and Solutions
Table 28. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AGENDIA NV Corporate Information, Location and Competitors
Table 30. AGENDIA NV Companion Diagnostic Tests Major Business
Table 31. AGENDIA NV Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 32. AGENDIA NV SWOT Analysis
Table 33. AGENDIA NV Companion Diagnostic Tests Product and Solutions
Table 34. AGENDIA NV Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Corporate Information, Location and Competitors
Table 36. Abbott Companion Diagnostic Tests Major Business
Table 37. Abbott Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Companion Diagnostic Tests Product and Solutions
Table 40. Abbott Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. BioMerieux SA, BioGenex Corporate Information, Location and Competitors
Table 42. BioMerieux SA, BioGenex Companion Diagnostic Tests Major Business
Table 43. BioMerieux SA, BioGenex Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 44. BioMerieux SA, BioGenex SWOT Analysis
Table 45. BioMerieux SA, BioGenex Companion Diagnostic Tests Product and Solutions
Table 46. BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genomic Health, Inc. Corporate Information, Location and Competitors
Table 48. Genomic Health, Inc. Companion Diagnostic Tests Major Business
Table 49. Genomic Health, Inc. Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 50. Genomic Health, Inc. SWOT Analysis
Table 51. Genomic Health, Inc. Companion Diagnostic Tests Product and Solutions
Table 52. Genomic Health, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Thermo Fisher Scientific, Inc. Corporate Information, Location and Competitors
Table 54. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Major Business
Table 55. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 56. Thermo Fisher Scientific, Inc. SWOT Analysis
Table 57. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product and Solutions
Table 58. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Companion Diagnostic Tests Revenue (Million USD) by Players (2015-2020)
Table 60. Global Companion Diagnostic Tests Revenue Share by Players (2015-2020)
Table 61. Global Companion Diagnostic Tests Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Companion Diagnostic Tests Revenue Market Share by Regions (2015-2020)
Table 63. North America Companion Diagnostic Tests Revenue by Countries (2015-2020)
Table 64. North America Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Table 65. Europe Companion Diagnostic Tests Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Companion Diagnostic Tests Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Companion Diagnostic Tests Revenue by Countries (2015-2020)
Table 68. South America Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Companion Diagnostic Tests Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Table 71. Global Companion Diagnostic Tests Revenue (Million USD) by Type (2015-2020)
Table 72. Global Companion Diagnostic Tests Revenue Share by Type (2015-2020)
Table 73. Global Companion Diagnostic Tests Revenue Forecast by Type (2021-2025)
Table 74. Global Companion Diagnostic Tests Revenue by Application (2015-2020)
Table 75. Global Companion Diagnostic Tests Revenue Share by Application (2015-2020)
Table 76. Global Companion Diagnostic Tests Revenue Forecast by Application (2021-2025)
Table 77. Global Companion Diagnostic Tests Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Companion Diagnostic Tests Picture
Figure 2. Global Companion Diagnostic Tests Revenue Market Share by Type in 2019
Figure 3. Protein Detection Picture
Figure 4. DNA Detection Picture
Figure 5. Hybridization Picture
Figure 6. Biomarker Picture
Figure 7. Others Picture
Figure 8. Companion Diagnostic Tests Revenue Market Share by Application in 2019
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Medical Device Companies Picture
Figure 11. Research Institutes Picture
Figure 12. Global Companion Diagnostic Tests Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Companion Diagnostic Tests Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Companion Diagnostic Tests Revenue Market Share in 2019
Figure 21. Global Top 10 Players Companion Diagnostic Tests Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Companion Diagnostic Tests Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Companion Diagnostic Tests Revenue Market Share by Regions (2015-2020)
Figure 25. Global Companion Diagnostic Tests Revenue Market Share by Regions in 2018
Figure 26. North America Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 27. Europe Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 29. South America Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 31. North America Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 32. North America Companion Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 33. USA Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 34. Canada Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 36. Europe Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Companion Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 38. Germany Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 39. UK Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 40. France Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 41. Russia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 42. Italy Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Companion Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 45. China Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 46. Japan Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 47. Korea Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 48. India Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 50. South America Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 51. South America Companion Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 52. Brazil Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Companion Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Companion Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 57. UAE Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 60. Global Companion Diagnostic Tests Revenue Share by Type (2015-2020)
Figure 61. Global Companion Diagnostic Tests Revenue Share by Type in 2019
Figure 62. Global Companion Diagnostic Tests Market Share Forecast by Type (2021-2025)
Figure 63. Global Protein Detection Revenue Growth Rate (2015-2020)
Figure 64. Global DNA Detection Revenue Growth Rate (2015-2020)
Figure 65. Global Hybridization Revenue Growth Rate (2015-2020)
Figure 66. Global Biomarker Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Companion Diagnostic Tests Revenue Share by Application (2015-2020)
Figure 69. Global Companion Diagnostic Tests Revenue Share by Application in 2019
Figure 70. Global Companion Diagnostic Tests Market Share Forecast by Application (2021-2025)
Figure 71. Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 72. Global Medical Device Companies Revenue Growth Rate (2015-2020)
Figure 73. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 74. Global Companion Diagnostic Tests Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Companion Diagnostic Tests Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Companion Diagnostic Tests Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 78. Europe Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 80. South America Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
F. Hoffman LA Roche Ltd.
Siemens Healthcare GmBH
Agilent Technologies, Inc.
QIAGEN, Illumina, Inc.
AGENDIA NV
Abbott
BioMerieux SA, BioGenex
Genomic Health, Inc.
Thermo Fisher Scientific, Inc.
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets